Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 15, 2026
Can you apply?
This grant is for faculty members at undergraduate-focused institutions and primarily undergraduate institutions (PUIs) that conduct clinical trials. Eligible applicants are typically researchers at two-year or four-year institutions whose primary mission is undergraduate education, rather than major research universities. The program supports early-stage research by providing funding for junior researchers to establish independent research careers. Projects must involve human subjects and include clinical trial components. Institutions must commit faculty and infrastructure support. Geographic scope is nationwide, and this is a federal NIH program with no geographic restrictions.
Not the right fit? Find grants for your organization in 5 questions →
Program description
The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students and enhancing the research environment at applicant institutions.Eligible institutions must award baccalaureate science degrees and have received no more than $6 million dollars per year of NIH support (in both direct and F and A/indirect costs) in 4 of the last 7 fiscal years. For institutions composed of multiple schools and colleges, the $6 million funding limit is based on the amount of NIH funding received by all the non-health professional schools and colleges within the institution as a whole.This Notice of Funding Opportunity (NOFO) supports investigator-initiated mechanistic and/or minimal risk clinical trials addressing the mission and research interests of the participating NIH institutes. For the purpose of this NOFO, minimal risk clinical trials are defined as those that do not require FDA oversight, do not intend to formally establish efficacy, and have low risks to potentially cause physical or psychological harm.
Who can apply
Eligible applicants
How to apply
Application links
Required documents
- NIH Form 398 (PHS 398) or electronic application through Grants.gov/eRA Commons
- Project Narrative (Research Strategy section with aims, background, significance, and clinical trial design)
- Budget and Budget Justification (detailed and realistic for clinical trial operations)
- Biographical Sketches of key personnel (PHS Form 5)
- Institutional Support Letter (demonstrating commitment to the research and mentoring)
- IRB approval or proof of human subjects certification
- Letter(s) of Collaboration (if external partners are involved)
- Facilities and Resources documentation
- Vertebrate Animals section (if applicable)
Program contact
- 👤 National Institutes of Health
- 📧 grantsinfo@nih.gov
- 📞 301-402-2541
Funding track record
Recent awards under CFDA 93.396 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$76,358,174
-
$48,037,195
-
$47,629,682
-
$45,540,324
-
$43,304,433
-
$38,522,746
-
$38,308,314
-
$31,389,631
-
$31,228,587
-
$31,069,673
Top States by Funding
- NY 17 awards $283.5M
- CA 17 awards $198.0M
- MA 18 awards $189.8M
- TX 6 awards $130.2M
- TN 7 awards $102.9M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.396). How funding has trended year over year.
| 2024 | $892,571,343 | |
| 2025 | $935,620,177 | |
| 2026 est. | $580,131,000 |
FAQ
What types of institutions are eligible to apply for the AREA R15?
Primarily undergraduate institutions, two-year institutions, and four-year institutions whose primary mission is undergraduate education. Major research universities are not eligible. Your institution must have a mission focused on undergraduate education rather than large-scale research.
Can my project be funded without a clinical trial component?
No, this variant of the R15 specifically requires a clinical trial. Projects without a human subjects component or clinical trial design will not be eligible for this funding mechanism.
What is the typical funding range and project duration?
While specific amounts vary by review cycle, AREA grants typically support smaller research budgets than R01 grants—commonly in the $100,000-$200,000 total costs range for 3-year projects, though you should verify current funding levels in the program announcement.
How competitive is this grant compared to R01?
The R15 is designed as an alternative to R01 for institutions with limited research infrastructure. It is generally less competitive than R01 grants because the applicant pool is restricted to PUIs, but quality and scientific rigor are still evaluated carefully. Strong preliminary data significantly strengthens competitiveness.
What are typical project timelines and when should I submit?
Projects are typically 3 years in duration. The next deadline shown is January 7, 2027. Plan to begin application preparation 3-4 months before the deadline to allow time for institutional review, internal approvals, and compliance checks.
💡 Tips for applicants
- Emphasize your institution's commitment to undergraduate research training and mentorship. Reviewers want to see how this project will involve students in meaningful research experiences and build their capacity.
- Develop strong preliminary data even though your institution may have fewer resources than R1 institutions. Preliminary results are critical for demonstrating feasibility and are often a deciding factor in AREA reviews.
- Detail the clinical trial design clearly, including recruitment strategy, informed consent procedures, and human subjects protections. The clinical trial requirement is central to this grant variant, so explain your regulatory pathway thoroughly.
- Build strong collaborations with more research-intensive institutions if needed, but ensure your PUI faculty member remains the scientific lead. NIH recognizes that junior faculty at undergraduate institutions may need mentoring partnerships.
- Address how limited infrastructure at your institution will not impede project success. Demonstrate access to patient populations, clinical facilities, or partnerships that enable clinical research despite being at a PUI.
⚠️ Common mistakes
Applications often fail because the clinical trial component is underdeveloped or unclear—reviewers need to see a realistic, well-designed protocol with appropriate human subjects safeguards. Additionally, many PUI applicants underestimate the administrative burden of managing a clinical trial, leading to budgets that don't adequately resource regulatory compliance, IRB coordination, or data management. Finally, some applications don't clearly articulate how undergraduate students will be integrated into the research, which undermines the educational mission of the AREA program.
Similar grants
- OPEN Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) — National Institutes of Health
- OPEN Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) — National Institutes of Health
- OPEN Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) — National Institutes of Health